| NDC Code | 0008-1222-14 |
|---|
| Package Description | 14 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0008-1222-14) |
|---|
| Product NDC | 0008-1222 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Pristiq |
|---|
| Proprietary Name Suffix | Extended-release |
|---|
| Non-Proprietary Name | Desvenlafaxine Succinate |
|---|
| Dosage Form | TABLET, EXTENDED RELEASE |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20080501 |
|---|
| Marketing Category Name | NDA |
|---|
| Application Number | NDA021992 |
|---|
| Manufacturer | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. |
|---|
| Substance Name | DESVENLAFAXINE SUCCINATE |
|---|
| Strength | 100 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC] |
|---|